Press release

Adents and Microsoft join their expertise in unit identification and Business Intelligence

Adents, software developer for unique product identification (UPID) and track & trace solutions, and Microsoft have decided to join forces.

Issy-les-Moulineaux (France) – Microsoft and Adents will develop and commercialize a Cloud platform named Adents Prodigi. Adents Prodigi is the only level 4 traceability solution that can centrally manage regulatory requirements imposed on the pharmaceutical industry and give laboratories and CMOs the ability to take advantage of the mass of information generated during the serialization and Track & Trace process.

Adents Prodigi opens up new horizons beyond regulatory compliance in terms of

  • Unit identification and traceability
  • The fight against counterfeit medicines
  • OEE and productivity monitoring across production sites
  • Enhanced user experience and personalized communication
  • Real-time data visualization and analysis

The demand for unique product identification solutions, Adents’ area of expertise, is fueled by a global increase in regulations, for instance, in the pharmaceutical industry where more than 80% of global drug production will have to be compliant with regulations regarding unit identification by 2019. This new process offers extraordinary opportunities in terms of visibility on the life of products and represents a major challenge in terms of data management.

Adents Prodigi relies on advanced Microsoft Azure technologies and allows drug manufacturers to securely generate, exchange and control the huge amount of data created through unit identification. The Adents Prodigi platform also integrates data analysis (including Microsoft Power BI) and machine learning tools, providing powerful analytics capabilities for these new sources of information.

Adents Prodigi is carried forward jointly by a mixed team of Adents and Microsoft experts and can host business applications offered by third parties to fully exploit the data stored on the platform. Adents Prodigi is the solution to ensure compliance with new regulations and at the same time exploit new data and better manage the business.

Bernard Ourghanlian, CTO & CSO at Microsoft France says

“ We are delighted that Adents has chosen Microsoft AZURE to develop the new solution that will manage the immense mass of data generated during a product’s life cycle. Microsoft’s Cloud platform will ensure the secure international deployment of Adents’ solution to accelerate the fight against industrial counterfeiting.

Our alliance with the leader of Business Intelligence will be a game changer on the global market for unit identification. Indeed, this will finally give the pharmaceutical industry the means to tap into the full potential of the wealth of information generated through serialization.”

adds Christophe Devins, founder and CEO of Adents.

Silvain Vernet


COVID-19: Adents' Business Continuity plan
The COVID-19 coronavirus epidemic has already affected thousands of people around the world and we expect the French government to announce stricter containment measures soon. Since Adents employees are mainly based in France and the United States, we take the health and economic risks linked to this epidemic very seriously.
Laboratoires Théa addresses European FMD and South Korea market regulation requirements with Adents Cloud serialization solution
Leading Ophtalmic Pharmaceuticals Company chose Adents Prodigi to connect with approximately 15 supply chain partners to stay compliant with current and future regulations.
Pharmascience Chooses Software from Adents to Ensure European FMD and US DSCSA Serialization Compliance Regulations
Pharmascience,the 4th largest manufacturer of over-the-counter and generic drugs in Canada, has chosen to partner with Adents, a leading provider of versatile and easily deployable serialization and track-and-trace software solutions, to assure compliance with the European Falsified Medicines Directive as well as the U.S. DSCSA serialization regulation.